Related Experiment Video
Updated: Mar 19, 2026
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
[MINIMALLY INVASIVE MULTIVESSEL CORONARY ARTERY BYPASS GRAFTING VIA SMALL LEFT THORACOTOMY]
Insights
Minimally invasive cardiac surgery coronary artery bypass grafting (MICS-CABG) offers cosmetic benefits and faster recovery. This approach shows promising mid-term results for multivessel coronary artery disease, potentially becoming a key treatment option.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Techniques
Context:
- Sternotomy approach remains the gold standard for multivessel coronary artery bypass grafting (CABG).
- Minimally invasive cardiac surgery CABG (MICS-CABG) via small left thoracotomy presents an alternative.
- MICS-CABG offers advantages in cosmesis and recovery time.
Purpose:
- To evaluate the safety and efficacy of MICS-CABG for multivessel coronary artery disease.
- To compare clinical outcomes of MICS-CABG with traditional sternotomy.
Summary:
- MICS-CABG demonstrates excellent clinical results with comparable mid-term graft patency to sternotomy.
- Successful utilization of bilateral internal thoracic arteries in MICS-CABG has been documented.
- While long-term durability and survival data are pending, MICS-CABG shows potential.
Impact:
- MICS-CABG is emerging as a viable and effective option for treating multivessel coronary artery disease.
- This approach may improve patient recovery and cosmetic outcomes.
- Further research is needed to confirm long-term benefits and address the technical learning curve.
Abstract:
Although a minithoracotomy approach has several advantages over a sternotomy approach in terms of superior cosmesis and faster recovery, coronary artery bypass grafting (CABG) via sternotomy has been the gold standard for revascularization in multivessel coronary artery disease. Recently, nonsternotomy approaches, including the minimally invasive cardiac surgery CABG (MICS-CABG) via small left thoracotomy, have emerged as safe, effective alternatives. Excellent clinical results have been reported including equivalent mid-term graft patency as compared with a sternotomy approach. Successful use of bilateral internal thoracic arteries in MICS-CABG has also been reported. Although the durability of this approach and its impact on long-term survival have yet to be confirmed, and there is a certain technical learning curve, MICS-CABG will be one important option to treat multivessel coronary artery disease.
